Clinical Hematology International

SAABRON PRESS

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical Hematology International is an open-access journal published by SAABRON PRESS in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAABRON PRESS
ISSN
2590-0048
Country
United States
Languages
english
Access
Open access
Articles in DOAJ
109
Declared review time
20 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2020-02-24
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

109

Most recent article

4 years ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

232

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

21

i10-index

52

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2024-03-13
Added to DOAJ
2020-02-24
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
91%
ORCID iDs in current deposits
55%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101759455
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

LCC codes

RC633-647.5

Subject areas

  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • CAR-T cell therapy research
Show all subjects (50)
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Childhood Cancer Survivors' Quality of Life
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Childhood Cancer Survivors' Quality of Life
  • Hemoglobinopathies and Related Disorders
  • Cutaneous lymphoproliferative disorders research
  • Cutaneous lymphoproliferative disorders research
  • Hemoglobinopathies and Related Disorders
  • Hematological disorders and diagnostics
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Hematological disorders and diagnostics
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Cytomegalovirus and herpesvirus research
  • Viral-associated cancers and disorders
  • COVID-19 Clinical Research Studies
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Cytomegalovirus and herpesvirus research
  • Viral-associated cancers and disorders
  • COVID-19 Clinical Research Studies
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments

Keywords (DOAJ)

  • cellular therapy
  • clinical haematology
  • cell transplantation
  • translational research
  • hematology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: